Portal de Periódicos da CAPES

THE IMPACT OF COLONY STIMULATING FACTORS ON CANCER CHEMOTHERAPY

1990; Wiley; Volume: 75; Issue: 3 Linguagem: Inglês

10.1111/j.1365-2141.1990.tb04340.x

1365-2141

George Morstyn,

Blood disorders and treatments

British Journal of HaematologyVolume 75, Issue 3 p. 303-307 THE IMPACT OF COLONY STIMULATING FACTORS ON CANCER CHEMOTHERAPY George Morstyn, Corresponding Author George Morstyn Joint Ludwig Institute, Austin Hospital Oncology UnitDr George Morstyn, Department of Medical Oncology, Royal Melbourne Hospital, Victoria, Australia 3050.Search for more papers by this author George Morstyn, Corresponding Author George Morstyn Joint Ludwig Institute, Austin Hospital Oncology UnitDr George Morstyn, Department of Medical Oncology, Royal Melbourne Hospital, Victoria, Australia 3050.Search for more papers by this author First published: July 1990 https://doi.org/10.1111/j.1365-2141.1990.tb04340.xCitations: 17AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Antin, J.H., Smith, B.R., Holmes, W. & Rosenthal, D.S. (1988) Phase I/II study of recombinant human granulocyte-macrophage colony-stlmulating factor in aplastic anemia and myelodysplastic syndrome. Blood, 72, 705–713. Antman, K.S., Griffin, J.D., Elias, A., Socinski, M.A., Ryan, L., Cannistra, S.A., Oette, D., Whitley, M., Frei, E., III & Schnipper, L.E. (1988) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppresslon. New England Journal of Medicine, 319, 593–598. Anmout, M.A., Wang, E.A., Clark, S.C. & Sieff, C.A. (1986) Human recomblnant granulocyte-macrophage colony-stimulating factor Increnses cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. Journal of Clinical Investigation, 78, 597–601. Baldwin, G.C., Dipersio, J., Kaufman, S.E., Quan, S.G., Golde, D.W. & Gasson, J.C. (1987) Characterization of human GM-CSF receptors on non-hematopoietic cells. Blood, Suppl. 70, 166A. Hishop, J.F., Raghavan, D., Stuart-Harris, R., Morstyn, G., Aroney, R., Kefford, R., Yuen, K., Lee, J., Gianoutsos, P., Olver, I.N., Zalcberg, J., Ball, D., Bull, C. & Fox, R. (1987) Carboplatin (CBDCA. JM-8) and VP16-213 in previously untreated patients with small cell lung cancer. Journal of Clinical Oncology, 5, 1574–1578. Bodey, G.P., Buckley, M., Sathe, Y.S. & Freireich, E.J. (1966) Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Annals of Internal Medcine, 64, 328–340. Brandt, S.J., Peters, W.P., Atwater, S.K., Kurtzberg, J., Borowitz, M.J., Jones, R.B., Shpall, E.J., Bast, R.C., Gilbert, C.J. & Oette, D.H. (1988) Effect of recombinant granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. New England Journal of Medicine, 318, 869–876. Baouchud, M.H., Scarffe, J.H., Thatcher, N., Crowther, D., Souza, L.M., Alton, N.K., Testa, N.G. & Dexter, T.M. (1987) Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. British Journal of Cancer, 56, 809–813. Bronchud, M.H., Howell, A., Crowther, D., Hopwood, P., Souza, L. & Dexter, T.M. (1989) The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patents with advanced breast and ovarian cancer. British Journal of Cancer, 60, 121–125. Broxmeyer, H.E., Cooper, S., Williams, D.E., Hangoc, G., Gutterman, J.U. & Vadhan-Raj, S. (1988) Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte macrophage colony-stimulating factor. Experimental Hematology, 16, 594–602. Cebon, J., Dempsey, P., Fox, R.M., Kannourakis, G., Bonnem, E., Burgess, A.W. & Morstyn, G. (1988) Pharmacokinetics of human granulocyte-macrophage colony stimulating factor (hGM-CSF) using a sensitive immunoassay. Blood, 72, 1340–1347. Oebon, J., Bury, R., Ueschke, J., O'Connor, M., Farrell, J. & Morstyn, G. (1990a) The pharmacokinetic correlates of GM-CSF efficacy and toxicity. (Abstract). ASCO 1990, in press. Cebon, J., Nicola, N., Ward, M., Gardner, I. Dempsey, P., Layton, J., Duhrsen, U., Burgess, A.W., Nice, E.C. & Morstyn, G. (1990b) Oranulocyte macrophage stimulating factor (hGM-CSF) from human lymphocytes: the effect of glycosylation on receptor bunting and biological activity. Journal of Biological Chemistry, 265, 4483–4491. Ledhar, S., Gaboury, L., Galloway, P. & Eaves, C. (1988) Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proceedings of the National Academy of Sciences of the United States of America, 85, 9253–9257. Devereux, S., Linch, D.C., Campos Costa, D., Spittle, M.F. & Jelliffe, A.M. (1987) Transient leucopenia induced by granulocyte-macrophage colony-stimulating factor. Lancet, ii, 1523–1524. Devereux, S., Bull, H.A., Campos Costa, D., Saib, R. & Linch, D.C. (1989) Granulocyte macrophage colony stimulating factor induced changes in cellular adhesion molecule expression and adhesion to endothelium: in vitro and in vivo studies in man. British Journal of Haematology, 71, 323–330. Donahue, R.E., Wang, E.A., Kaufman, R.J., Fouch, L., Leary, A.C., Witek-Gigretti, J.S., Mertzger, M., Hewick, R.M., Steinbrink, D.R., Shaw, G., Kamen, R. & Clark, S.C. (1986) Effects of N-linked carbohydrate on the in vivo properties of human GM-CSF. Cold Spring Harbor Symposium on Quantitative Biology, 51, 685–692. Dührsen, U., Villeval, J.L., Boyd, J., Kannourakis, G., Morstyn, G. & Metcalf, D. (1988) Effects of recombinant human granulocyte colony stimulating factor on hemopoietic progenitor cells in cancer patients. Blood, 72, 2074–2081. Edmonson, J.H. (1989) Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency. Journal of the Cancer Institute, 81, (9), 1510–1512. Eguchi, K., Sasaki, S., Tamura, T., Sasaki, Y., Shinkai, T., Yamada, K., Soejima, Y., Fukuda, M., Fujihara, Y., Konitou, H., Tobinai, K., Ohtsu, T., Suemasu, K., Takaku, F. & Saijo, N. (1989) Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancy. Cancer Research, 49, 5221–5224. Gabrilove, J.L., Jakubowski, A., Fain, K., Grous, J., Scher, H., Sternberg, C., Yagoda, A., Clarkson, B., Bonilla, M.A., Oettgen, H.F., Alton, K., Boone, T., Altrock, B., Welte, K. & Souza, L. (1988a) Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. Journal of Clinical Investigation, 82, 1454–1461. Gabrilove, J.L., Jakubowski, A., Scher, H., Sternberg, C., Wong, G., Grous, J., Yagoda, A., Fain, K., Moore, M.A.S., Clarkson, B., Oettgen, H.F., Alton, K., Welte, K. & Souza, L. (1988b) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. New England Journal of Medicine, 318, 1414–1422. Hermann, F., Wieser, M., Schulz, G., Lindemann, A., Oster, W. & Mertelsmann, R. (1988) Single daily subcutaneous administration of rhGM-CSF ameliorates hematopoietic toxicity of chemotherapy in outpatients. Blood Abstract, 390, p. 120, Supplement. Hermann, F., Schulz, G., Lindemann, A., Meyenburg, W., Oster, W., Krumwieh, D. & Mertelsman, R. (1989) Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor. Journal of Clinical Oncology, 7, 159–167. Kaushansky, K., O'hara, P.J., Hart, C.E., Forstrom, J.W. & Hagen, F.S. (1987) Role of carbohydrate in the function of human granulocyte-macrophage colony-stimulating factor. Biochemistry, 26, 4861–4867. Kobayashi, Y., Okabe, T., Ozawa, K., Chiba, S., Hino, M., Miyazono, K., Urabe, A. & Takaku, F. (1989) Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report. American Journal of Medicine, 85, 178–182. Layton, J.E., Hockman, H., Sheridan, W.P. & Morstyn, G. (1989) Evidence for a novel in vivo control mechanism of hemopoiesis: mature cell control of a regulatory growth factor. Blood, 74, 1303–1307. Lieschke, G.J., Cebon, J. & Morstyn, G. (1989a) Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor. Blood, 74, 2634–2643. Lieschke, G.J., Maher, D., Cebon, J., O'Connor, P., Green, M., Sheridan, W., Boyd, A., Rallings, M., Bonnem, E., Metcalf, D., Burgess, A.W., McGrath, K., Fox, R.M. & Morstyn, G. (1989b) Effects of subcutaneously administered bacterially-synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. Annals of Internal Medicine, 110, 357–364. Lieschke, G.J., Maher, D., O'Connor, M., Green, M., Sheridan, W., Rallings, M., Bonnem, E., Burgess, A.W., McGrath, K., Fox, R. & Morstyn, G. (1989c) Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration. Cancer Research, 50, 606–614. Lindemann, A., Herrmann, F., Oster, W., Haffner, G., Meyenburg, W., Souza, L.M. & Mertelsmann, R. (1989) Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood, 74, 2644–2651. Lord, B.I., Bronchud, M.H., Owens, S., Chang, J., Howell, A., Souza, L. & Dexter, T.M. (1989) The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proceedings of the National Academy of Sciences of the United States of America, 86, 9499–9503. Metcalf, D. & Morstyn, G. (1989) The colony stimulating factor. General biology and clinical use. In: Principles of Biological Therapy (ed. by Vita et al). Moonen, P., Mermod, J.J., Ernst, J.F., Hirschi, M. & DeLamarter, J.F. (1987) increased biological activity of deglycosylated recombinant human granulocyte/macrophage colony-stimulating factor produced by yeast or animal cells. Proceedings of the National Academy of Sciences of the United States of America, 84, 4428–4431. Morstyn, G., Campbell, L., Souza, L.M., Alton, N.K., Keech, J., Green, M., Sheridan, W., Metcalf, D. & Fox, R. (1988) Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet, ii, 667–672. Morstyn, G., Campbell, L., Lieschke, G.J., Layton, J.E., Maher, D., Green, M., Sheridan, W., Vincent, M., Alton, K., Souza, L., McGrath, K. & Fox, R.M. (1989a) Abrogation of chemotherapy induced neutropenia by subcutaneously administered granulocyte colony stimulating factor (G-CSF) with optimization of dose and duration of therapy. Journal of Clinical Oncology, 7, 1–9. Morstyn, G., Lieschke, G., Cebon, J. & Layton, J. (1989b) Pharmacology of the colony stimulating factors. TIPS, 10, 154–159. Morstyn, G., Lieschke, J.G., Cebon, J., Duhrsen, U., Villeval, J.C., Sheridan, W., McGrath, K. & Layton, J.E. (1989c) Early clinical trials with colony stimulating factors. Cancer Investigations, 7, 443–456. Morstyn, G., Lieschke, G., Sheridan, W., Layton, J., Cebon, J. & Fox, R.M. (1989d) Clinical experience with recombinant human G-CSF and GM-CSF. Seminars in Hematology, 26, 9–13 (Suppl. 2). Morstyn, G., Ramenghi, U., Lieschke, G.J., Bishop, J.F., Stuart-Harris, R., Kefford, R.F., Raghavan, D., Cebon, J., Layton, J.E. & Sheridan, W. (1989e) The impact of granulocyte-colony stimulating factor (G-CSF) and granulocyte macrophage colony stimulating factor (GM-CSF) on cancer therapy. Views on Cancer. General Motors Research Foundation, New York . Morstyn, G., Stuart-Harris, R., Bishop, J., Raghavan, D., Kefford, R., Lieschke, G., Bonnem, E., Olver, I., Green, M., Rallings, M. & Fox, R. (1989f) Optimal scheduling of granulocyte-macrophage colony-stimulating factor for the abrogation of chemotherapy induced neutropenia in small cell lung cancer. (Abstract). Proceedings of the American Society for Clinical Oncology, 8, 850. Neumanitis, J., Singer, J.W., Buckner, C.D., Hill, R., Storb, R., Thomas, E.D. & Appelbaum, F.R. (1988) Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood, 72, 834–836. Peters, W.P., Shogan, J., Shpall, E.J., Jones, R.B. & Kim, C.S. (1988a) Recombinant human granulocyte-macrophage colony-stimulating factor produces fever. Lancet, i, 950. Peters, W.P., Stuart, A., Affronti, M.L., Kim, C.S. & Coleman, R.E. (1988b) Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans. Blood, 72, 1310–1315. Rifkin, R.M., Hersh, E.M. & Salmon, S.E. (1988) A phase I study of therapy with recombinant granulocyte-macrophage colony stimulating factor administered by IV bolus or continuous infusion. Behring Institut Mitteilung, 83, 125–133. Sheridan, W.P., Morstyn, G., Wolf, M., Dodds, A., Lusk, J., Maher, D., Layton, J.E., Green, M.D., Souza, L. & Fox, R.M. (1989) Effects of granulocyte colony stimulating factor (G-CSF) following high dose chemotherapy and autologous bone marrow transplantation. Lancet, ii, 891–895. Socinski, M.A., Cannistra, S.A., Elias, A., Antman, K.H., Schnipper, L. & Griffin, J.D. (1988) Granulocyte macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet, i, 1194–1198. Thompson, J.A., Lee, D.J., Kidd, R.E., Kaufmann, J., Bonnem, E.M. & Fefer, A. (1989) Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics and hematological effects. Journal of Clinical Oncology, 7, 629–637. To, L.B., Dyson, P.G., Branford, A.L., Russell, J.A., Haylock, D.N., Ho, J.Q., Kimber, R.J. & Juttner, C.A. (1987) Peripheral blood stem cells collected in very early remission produce rapid and sustained autologous haemopoietic reconstitution in acute non-lympho-blastic leukaemia. Bone Marrow Transplantation, 2, 103–108. Vadhan-Raj, S., Keating, M., Lemaistre, A., Hittelman, W.N., McCredie, K., Trujillo, J.M., Broxmeyer, H.E., Henney, C. & Gutterman, J.U. (1987) Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. New England Journal of Medicine, 317, 1545–1552. Vadhan-Raj, S., Buescher, S., Lemaistre, A., Keating, M., Walters, R., Ventura, C., Hittelman, W., Broxmeyer, H.E. & Gutterman, J.U. (1988) Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage stimulating-factor. Blood, 72, 134–141. Wright, D.G., Meierovics, A.I. & Foxley, J.M. (1986) Assessing the delivery of neutrophils to tissues in neutropenia. Blood, 67, 1023–1030. Citing Literature Volume75, Issue3July 1990Pages 303-307 ReferencesRelatedInformation